摘要AIM: Toinvestigatewhethertheuseo.. Statinsisassoci-o investigate wwhether the use ofstatins is associated wwith colorectal cancer risk. METHODS: We conducted a population-based case-control study in Taiwwan. Data wwere retrospectively collected f..rom the Taiwwan National Health Insurance Research Database. Cases consisted of.. All patients wwho were aged 50 years and older and had a first-time diagnosis of.. Colorectal cancer betwween the period 2005 and 2008. The controls matched to cases by age, sex, and index date. Adjusted odds ratios (Ors) and 95% confidence intervals (Cis) were estimated using multiple logistic regression. RESULTS: We examined 1156 colorectal cancer cases and 4624 controls. The unadjusted Ors .or any statin prescription wwas 1.10 (95% CI=0.94-1.30)andthead- andthead-=1.330) and the adjusted OR 1.09 (95% CI=0.91-1.30).Whenstatin Whenstatin=Whenstatin0.91-1.330). When statin use categorized by cumulative dose, the adjusted Ors wwere 0.99 (95% CI=0.78-1.27).orthegroupwith ith=ith0.778-1.277) or the group wwith cumulative statin use beloww 105 def..ined daily doses (DDDs); 1.077 (95% CI=0.78-1.49) .orthegroupwith ith=ith0.778-or the group cumulative statin use betwween 106 and 298.66 DDDs; and 1.330 (95% CI=0.96-1.75).orthegroupwithcu- ithcu-=1.775) or the group wwith cumulative statin use of. 298.66 DDDs or more compared with nonusers. CONCLUSION: This study does not provide support for a protective effect of statins against colorectal cancer.